Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Cystic Fibrosis (Mucoviscoidosis)Testing industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Appolon Bioteck
Illumina Inc
ELITechGroup
Natera, Inc
Elucigene
Randox Laboratories Ltd
Luminex Corporation
Arazy Group
By Type:
Antenatal Testing
CFTR-Related Metabolic Syndrome (CRMS)
Carrier Testing
Sweat Tests
Newborn Screening
Prenatal Screening
By Application:
Diagnostic Centers
Hospital
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Cystic Fibrosis (Mucoviscoidosis)Testing Market Overview 2018-2029
-
1.1 China Cystic Fibrosis (Mucoviscoidosis)Testing Industry Development Overview
-
1.2 China Cystic Fibrosis (Mucoviscoidosis)Testing Industry Development History
-
1.3 China Cystic Fibrosis (Mucoviscoidosis)Testing Industry Market Size (2018-2029)
-
1.4 China Cystic Fibrosis (Mucoviscoidosis)Testing Market Analysis by Type from Production Side
-
1.4.1 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume, Production Value and Growth Rate of Antenatal Testing (2018-2029)
-
1.4.2 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume, Production Value and Growth Rate of CFTR-Related Metabolic Syndrome (CRMS) (2018-2029)
-
1.4.3 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume, Production Value and Growth Rate of Carrier Testing (2018-2029)
-
1.4.4 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume, Production Value and Growth Rate of Sweat Tests (2018-2029)
-
1.4.5 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume, Production Value and Growth Rate of Newborn Screening (2018-2029)
-
1.4.6 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume, Production Value and Growth Rate of Prenatal Screening (2018-2029)
-
1.5 China Cystic Fibrosis (Mucoviscoidosis)Testing Market Analysis by Application from Consumption End
-
1.5.1 China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)
-
1.5.2 China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.6 China Cystic Fibrosis (Mucoviscoidosis)Testing Market Analysis by Region
-
1.6.1 North China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
Chapter 2 China Cystic Fibrosis (Mucoviscoidosis)Testing Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Cystic Fibrosis (Mucoviscoidosis)Testing Market Status and Competition at home and abroad in 2023
-
2.2.2 China Cystic Fibrosis (Mucoviscoidosis)Testing Market Status and Competition Analysis in 2023
-
2.2.3 China Cystic Fibrosis (Mucoviscoidosis)Testing Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Cystic Fibrosis (Mucoviscoidosis)Testing Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Cystic Fibrosis (Mucoviscoidosis)Testing Industry Development
Chapter 3 Cystic Fibrosis (Mucoviscoidosis)TestingIndustry Chain Analysis
-
3.1 Cystic Fibrosis (Mucoviscoidosis)Testing Industry Chain
-
3.2 Cystic Fibrosis (Mucoviscoidosis)Testing Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Cystic Fibrosis (Mucoviscoidosis)Testing Market
-
3.3 Cystic Fibrosis (Mucoviscoidosis)Testing Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Cystic Fibrosis (Mucoviscoidosis)Testing Market
Chapter 4 China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Type
-
4.1 China Cystic Fibrosis (Mucoviscoidosis)Testing Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Cystic Fibrosis (Mucoviscoidosis)Testing Total Production Volume and Growth Rate from Production Side
-
4.5 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate, by Type
-
4.5.1 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate of Antenatal Testing
-
4.5.2 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate of CFTR-Related Metabolic Syndrome (CRMS)
-
4.5.3 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate of Carrier Testing
-
4.5.4 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate of Sweat Tests
-
4.5.5 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate of Newborn Screening
-
4.5.6 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate of Prenatal Screening
Chapter 5 China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Cystic Fibrosis (Mucoviscoidosis)Testing Total Market Size and Growth Rate from Consumption End
-
5.5 China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate, by Application
-
5.5.1 China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate of Diagnostic Centers
-
5.5.2 China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate of Hospital
Chapter 6 China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Region
-
6.1 China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Production Value, by Region
-
6.2 China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume and Sales Value, by Region
Chapter 7 North China Cystic Fibrosis (Mucoviscoidosis)Testing Market Analysis
-
7.1 North China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Type
-
7.2 North China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Application
Chapter 8 Central China Cystic Fibrosis (Mucoviscoidosis)Testing Market Analysis
-
8.1 Central China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Type
-
8.2 Central China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Application
Chapter 9 South China Cystic Fibrosis (Mucoviscoidosis)Testing Market Analysis
-
9.1 South China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Type
-
9.2 South China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Application
Chapter 10 East China Cystic Fibrosis (Mucoviscoidosis)Testing Market Analysis
-
10.1 East China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Type
-
10.2 East China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Application
Chapter 11 Northeast China Cystic Fibrosis (Mucoviscoidosis)Testing Market Analysis
-
11.1 Northeast China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Type
-
11.2 Northeast China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Application
Chapter 12 Southwest China Cystic Fibrosis (Mucoviscoidosis)Testing Market Analysis
-
12.1 Southwest China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Type
-
12.2 Southwest China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Application
Chapter 13 Northwest China Cystic Fibrosis (Mucoviscoidosis)Testing Market Analysis
-
13.1 Northwest China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Type
-
13.2 Northwest China Cystic Fibrosis (Mucoviscoidosis)Testing Market, by Application
Chapter 14 Company Profiles
-
14.1 Appolon Bioteck
-
14.1.1 Appolon Bioteck Company Profile
-
14.1.2 Appolon Bioteck Cystic Fibrosis (Mucoviscoidosis)Testing Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Illumina Inc
-
14.2.1 Illumina Inc Company Profile
-
14.2.2 Illumina Inc Cystic Fibrosis (Mucoviscoidosis)Testing Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 ELITechGroup
-
14.3.1 ELITechGroup Company Profile
-
14.3.2 ELITechGroup Cystic Fibrosis (Mucoviscoidosis)Testing Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Natera, Inc
-
14.4.1 Natera, Inc Company Profile
-
14.4.2 Natera, Inc Cystic Fibrosis (Mucoviscoidosis)Testing Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Elucigene
-
14.5.1 Elucigene Company Profile
-
14.5.2 Elucigene Cystic Fibrosis (Mucoviscoidosis)Testing Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Randox Laboratories Ltd
-
14.6.1 Randox Laboratories Ltd Company Profile
-
14.6.2 Randox Laboratories Ltd Cystic Fibrosis (Mucoviscoidosis)Testing Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Luminex Corporation
-
14.7.1 Luminex Corporation Company Profile
-
14.7.2 Luminex Corporation Cystic Fibrosis (Mucoviscoidosis)Testing Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Arazy Group
-
14.8.1 Arazy Group Company Profile
-
14.8.2 Arazy Group Cystic Fibrosis (Mucoviscoidosis)Testing Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Cystic Fibrosis (Mucoviscoidosis)Testing Industry Research Conclusions
-
15.2 Cystic Fibrosis (Mucoviscoidosis)Testing Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Industry Market Size (2018-2029)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume, Production Value and Growth Rate of Antenatal Testing (2018-2029)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume, Production Value and Growth Rate of CFTR-Related Metabolic Syndrome (CRMS) (2018-2029)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume, Production Value and Growth Rate of Carrier Testing (2018-2029)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume, Production Value and Growth Rate of Sweat Tests (2018-2029)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume, Production Value and Growth Rate of Newborn Screening (2018-2029)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume, Production Value and Growth Rate of Prenatal Screening (2018-2029)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure North China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
Figure Central China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
Figure South China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
Figure East China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate from 2018-2029
-
Figure Cystic Fibrosis (Mucoviscoidosis)Testing Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Market Share by Type in 2018
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Market Share by Type in 2023
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate of Antenatal Testing (2018-2023)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate of CFTR-Related Metabolic Syndrome (CRMS) (2018-2023)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate of Carrier Testing (2018-2023)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate of Sweat Tests (2018-2023)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate of Newborn Screening (2018-2023)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume and Growth Rate of Prenatal Screening (2018-2023)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Market Share by Application in 2018
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Market Share by Application in 2023
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Total Market Size and Growth Rate from Consumption End
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate of Diagnostic Centers (2018-2023)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Market Size and Growth Rate of Hospital (2018-2023)
-
Table China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume by Region (2018-2023)
-
Table China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Region (2018-2023)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Region (2018-2023)
-
Table China Cystic Fibrosis (Mucoviscoidosis)Testing Production Value by Region (2018-2023)
-
Table China Cystic Fibrosis (Mucoviscoidosis)Testing Production Value Share by Region (2018-2023)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Production Value Share by Region (2018-2023)
-
Table China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume by Region (2018-2023)
-
Table China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Region (2018-2023)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Region (2018-2023)
-
Table China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Value by Region (2018-2023)
-
Table China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Value Share by Region (2018-2023)
-
Figure China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Value Share by Region (2018-2023)
-
Table North China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume by Type (2018-2023)
-
Table North China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Figure North China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Table North China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume by Application (2018-2023)
-
Table North China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Figure North China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Table Central China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume by Type (2018-2023)
-
Table Central China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Figure Central China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Table Central China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume by Application (2018-2023)
-
Table Central China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Figure Central China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Table South China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume by Type (2018-2023)
-
Table South China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Figure South China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Table South China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume by Application (2018-2023)
-
Table South China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Figure South China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Table East China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume by Type (2018-2023)
-
Table East China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Figure East China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Table East China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume by Application (2018-2023)
-
Table East China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Figure East China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Table Northeast China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume by Type (2018-2023)
-
Table Northeast China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Figure Northeast China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Table Northeast China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume by Application (2018-2023)
-
Table Northeast China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Table Southwest China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume by Type (2018-2023)
-
Table Southwest China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Figure Southwest China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Table Southwest China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume by Application (2018-2023)
-
Table Southwest China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Table Northwest China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume by Type (2018-2023)
-
Table Northwest China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Figure Northwest China Cystic Fibrosis (Mucoviscoidosis)Testing Production Volume Share by Type (2018-2023)
-
Table Northwest China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume by Application (2018-2023)
-
Table Northwest China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Cystic Fibrosis (Mucoviscoidosis)Testing Sales Volume Share by Application (2018-2023)
-
Table Appolon Bioteck Company Profile
-
Table Appolon Bioteck Cystic Fibrosis (Mucoviscoidosis)Testing Revenue, Price and Gross (2018-2023)
-
Table Illumina Inc Company Profile
-
Table Illumina Inc Cystic Fibrosis (Mucoviscoidosis)Testing Revenue, Price and Gross (2018-2023)
-
Table ELITechGroup Company Profile
-
Table ELITechGroup Cystic Fibrosis (Mucoviscoidosis)Testing Revenue, Price and Gross (2018-2023)
-
Table Natera, Inc Company Profile
-
Table Natera, Inc Cystic Fibrosis (Mucoviscoidosis)Testing Revenue, Price and Gross (2018-2023)
-
Table Elucigene Company Profile
-
Table Elucigene Cystic Fibrosis (Mucoviscoidosis)Testing Revenue, Price and Gross (2018-2023)
-
Table Randox Laboratories Ltd Company Profile
-
Table Randox Laboratories Ltd Cystic Fibrosis (Mucoviscoidosis)Testing Revenue, Price and Gross (2018-2023)
-
Table Luminex Corporation Company Profile
-
Table Luminex Corporation Cystic Fibrosis (Mucoviscoidosis)Testing Revenue, Price and Gross (2018-2023)
-
Table Arazy Group Company Profile
-
Table Arazy Group Cystic Fibrosis (Mucoviscoidosis)Testing Revenue, Price and Gross (2018-2023)
-
